Home/Filings/4/0000899243-22-015855
4//SEC Filing

Wooldridge James 4

Accession 0000899243-22-015855

CIK 0001651431other

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 5:03 PM ET

Size

5.5 KB

Accession

0000899243-22-015855

Insider Transaction Report

Form 4
Period: 2021-03-04
Wooldridge James
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-03-04+54,60054,600 total
    Exercise: $13.50Exp: 2031-03-03Common Stock (54,600 underlying)
Footnotes (1)
  • [F1]This stock option shall vest 25% on the first anniversary of the vesting start date of March 5, 2021 and in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Persons continued service through such date.

Issuer

Checkmate Pharmaceuticals, Inc.

CIK 0001651431

Entity typeother

Related Parties

1
  • filerCIK 0001710641

Filing Metadata

Form type
4
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 5:03 PM ET
Size
5.5 KB